Dynamic’s area of expertise covers the life sciences industry, with particular emphasis on medical device and pharmaceutical companies.
Life sciences companies face a broad, complex and constantly changing set of challenges. They are required to keep pace with the rapid development of innovative equipment and therapies that incorporate scientific and technological advances, and that address patient needs. Additionally, they must maintain product quality standards, adhere to stringent regulatory requirements, and manage production costs in a highly competitive market.
Beyond these business issues, life sciences companies must contend with the human factors associated with their products. Malfunctions or failures not only affect finances and brand reputation; the lives and safety of patients are also at stake. And in our increasingly connected world, the security of patient data is at greater risk.
Dynamic’s services – encompassing product design, development, validation, production, lifecycle management and transition – cover a range of specific applications.
In the medical device sector, our applications primarily cover:
• In Vitro Diagnostics
• Lab Automation
• Diagnostic Devices
• Imaging Devices
• Surgical Devices
In the pharmaceutical sector, our applications primarily cover:
• Clinical Trials
• Lab Automation
• Wearable Devices
• New Technologies, including 3D Printing
Dynamic understands the complex challenges and opportunities involved in the life sciences industry. Our intense focus on quality, compliance and risk management are the reasons why we have been trusted partners for so many years with some of the most successful and respected companies in this sector.
Coming out of the COVID-19 pandemic, many organizations are considering digital transformation as the key to ensuring supply chain resilience. Evolutions in technologies have enabled
Sustainability is a critical issue for many businesses, fueled by growing internal and external pressure to measure and strengthen environmental, social, and governance (ESG) practices.
When we think of supply chain disruptions, we usually only consider the shortages that became familiar during the pandemic—back-ordered or unavailable parts, empty store shelves,
